Bank of America’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-21,777
| Closed | -$387K | – | 7625 |
|
|
2018
Q3 | $387K | Buy |
21,777
+11,436
| +111% | +$196K | ﹤0.01% | 5122 |
|
|
2018
Q2 | $142K | Sell |
10,341
-42,658
| -80% | -$506K | ﹤0.01% | 5608 |
|
|
2018
Q1 | $482K | Sell |
52,999
-14,511
| -21% | -$80.1K | ﹤0.01% | 4836 |
|
|
2017
Q4 | $289K | Buy |
67,510
+64,601
| +2,221% | +$308K | ﹤0.01% | 5243 |
|
|
2017
Q3 | $4K | Sell |
2,909
-11,768
| -80% | -$16.4K | ﹤0.01% | 6793 |
|
|
2017
Q2 | $22K | Sell |
14,677
-235
| -2% | -$505 | ﹤0.01% | 6203 |
|
|
2017
Q1 | $39K | Buy |
14,912
+4,609
| +45% | +$10.7K | ﹤0.01% | 6040 |
|
|
2016
Q4 | $26K | Buy |
10,303
+5,959
| +137% | +$17.1K | ﹤0.01% | 6237 |
|
|
2016
Q3 | $13K | Sell |
4,344
-5,524
| -56% | -$17.2K | ﹤0.01% | 6305 |
|
|
2016
Q2 | $31K | Buy |
9,868
+8,834
| +854% | +$32.4K | ﹤0.01% | 6062 |
|
|
2016
Q1 | $3K | Sell |
1,034
-9,163
| -90% | -$29.9K | ﹤0.01% | 6732 |
|
|
2015
Q4 | $41K | Buy |
10,197
+8,421
| +474% | +$38.8K | ﹤0.01% | 6130 |
|
|
2015
Q3 | $8K | Sell |
1,776
-2,226
| -56% | -$11.6K | ﹤0.01% | 6656 |
|
|
2015
Q2 | $21K | Buy |
4,002
+3,877
| +3,102% | +$23.3K | ﹤0.01% | 6319 |
|
|
2015
Q1 | $1K | Sell |
125
-55
| -31% | -$317 | ﹤0.01% | 6921 |
|
|
2014
Q4 | $1K | Sell |
180
-228
| -56% | -$1.39K | ﹤0.01% | 7589 |
|
|
2014
Q3 | $2K | Sell |
408
-39,234
| -99% | -$268K | ﹤0.01% | 7827 |
|
|
2014
Q2 | $261K | Buy |
39,642
+37,981
| +2,287% | +$428K | ﹤0.01% | 5302 |
|
|
2014
Q1 | $40K | Sell |
1,661
-324
| -16% | -$4.7K | ﹤0.01% | 6561 |
|
|
2013
Q4 | $21K | Sell |
1,985
-5,013
| -72% | -$55.4K | ﹤0.01% | 7012 |
|
|
2013
Q3 | $93K | Sell |
6,998
-4,767
| -41% | -$75.4K | ﹤0.01% | 6030 |
|
|
2013
Q2 | $154K | Buy |
+11,765
| New | +$159K | ﹤0.01% | 5864 |
|
Other funds holding ECYT
Bank of America's ECYT Position: Q4 2018 in Review
Bank of America sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 21,777 shares — an estimated $387K sold.
Bank of America first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $482K in Q1 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Bank of America reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Bank of America sold 21,777 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $387K.
- Bank of America first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
- Bank of America's Endocyte, Inc. Common Stock position peaked at $482K in Q1 2018.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Bank of America's 13F filing for Q4 2018, filed 14 Feb 2019.